incretin mimetic agents glp 1 receptor agonists Introduction to Diabetes Type and Type 2 GLP-1 Receptor Agonists and Research
Description
However, it remains under investigation whether these benefits are directly due to the GLP-1 agonists or a result of the weight loss they facilitate
The current study cannot fully separate those possibilities
Most of the weight tends to return after stopping (Wilding 2022)
7 The illness, primarily affecting obese women of reproductive age, causes severe symptoms such as recurrent headaches and papilledema, potentially causing irreversible vision impairment if ignored
It is intended for individuals who are overweight or obese and need help losing weight
